NO961813D0 - Adhesjonsreseptorantagonister - Google Patents

Adhesjonsreseptorantagonister

Info

Publication number: NO961813D0
Authority: NO; Norway
Prior art keywords: adhesjonsreseptorantagonister
Prior art date: 1995-05-05

Application number

NO961813A

Other languages

English (en)

Other versions

NO961813L (no

NO305906B1 (no

Inventor

Joachim Gante

Horst Juraszyk

Peter Raddatz

Hanns Wurziger

Sabine Bernotat-Danielowski

Guido Melzer

Original Assignee

Merck Patent Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-05-05

Filing date

1996-05-03

Publication date

1996-05-03

1996-05-03 Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh

1996-05-03 Publication of NO961813D0 publication Critical patent/NO961813D0/no

1996-11-06 Publication of NO961813L publication Critical patent/NO961813L/no

1999-08-16 Publication of NO305906B1 publication Critical patent/NO305906B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/20—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having nitrogen atoms of amidino groups acylated
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/14—Nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Hematology (AREA)
Physical Education & Sports Medicine (AREA)
Diabetes (AREA)
Immunology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Rheumatology (AREA)
Oncology (AREA)
Orthopedic Medicine & Surgery (AREA)
Communicable Diseases (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Biomedical Technology (AREA)
Transplantation (AREA)
Obesity (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Plural Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO961813A 1995-05-05 1996-05-03 Adhesjonsreseptorantagonister, farmasöytiske preparater som inneholder slike forbindelser, samt anvendelse av forbindelsene til fremstilling av legemidler NO305906B1 (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19516483A DE19516483A1 (de)	1995-05-05	1995-05-05	Adhäsionsrezeptor-Antagonisten

Publications (3)

Publication Number	Publication Date
NO961813D0 true NO961813D0 (no)	1996-05-03
NO961813L NO961813L (no)	1996-11-06
NO305906B1 NO305906B1 (no)	1999-08-16

Family

ID=7761137

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO961813A NO305906B1 (no)	1995-05-05	1996-05-03	Adhesjonsreseptorantagonister, farmasöytiske preparater som inneholder slike forbindelser, samt anvendelse av forbindelsene til fremstilling av legemidler

Country Status (25)

Country	Link
US (1)	US6455529B1 (no)
EP (1)	EP0741133B1 (no)
JP (1)	JP4202438B2 (no)
KR (1)	KR100462176B1 (no)
CN (1)	CN1134423C (no)
AR (1)	AR003121A1 (no)
AT (1)	ATE258548T1 (no)
AU (1)	AU708813B2 (no)
BR (1)	BR9602150A (no)
CA (1)	CA2175767C (no)
CO (1)	CO4950623A1 (no)
CZ (1)	CZ291621B6 (no)
DE (2)	DE19516483A1 (no)
DK (1)	DK0741133T3 (no)
ES (1)	ES2213758T3 (no)
HU (1)	HUP9601176A3 (no)
NO (1)	NO305906B1 (no)
PL (1)	PL187000B1 (no)
PT (1)	PT741133E (no)
RU (1)	RU2162086C2 (no)
SK (1)	SK282563B6 (no)
TR (1)	TR199600359A2 (no)
TW (1)	TW378205B (no)
UA (1)	UA53608C2 (no)
ZA (1)	ZA963535B (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19653647A1 (de)	1996-12-20	1998-06-25	Hoechst Ag	Vitronectin - Rezeptorantagonisten, deren Herstellung sowie deren Verwendung
US6218387B1 (en)	1996-12-20	2001-04-17	Hoechst Aktiengesellschaft	Vitronectin receptor anatagonists, their preparation and their use
DE19653645A1 (de) *	1996-12-20	1998-06-25	Hoechst Ag	Vitronectin - Rezeptorantagonisten, deren Herstellung sowie deren Verwendung
US6482821B2 (en)	1996-12-20	2002-11-19	Hoechst Aktiengellschaft	Vitronectin receptor antagonists, their preparation and their use
DE19755268A1 (de) *	1997-12-12	1999-06-17	Merck Patent Gmbh	Benzamidinderivate
AU1687699A (en) *	1997-12-25	1999-07-19	Yamanouchi Pharmaceutical Co., Ltd.	Nitrogenous heterocyclic derivatives
SK18362000A3 (sk)	1998-06-05	2001-06-11	Astrazeneca Ab	Oxazolidinónové deriváty, spôsob ich prípravy a farmaceutické kompozície, ktoré ich obsahujú
JP2002533404A (ja)	1998-12-23	2002-10-08	ジー・ディー・サール・アンド・カンパニー	新生物形成の治療における組合わせ療法としてインテグリン拮抗剤及び放射線治療を使用する方法
CA2368049A1 (en)	1999-04-13	2000-10-19	Basf Aktiengesellschaft	Integrin receptor ligands
WO2000078318A1 (en) *	1999-06-18	2000-12-28	Yamanouchi Pharmaceutical Co., Ltd.	Medicinal composition for oral administration
GB9928568D0 (en) *	1999-12-03	2000-02-02	Zeneca Ltd	Chemical compounds
AU2001253113B2 (en) *	2000-04-20	2005-02-03	Pharmacia & Upjohn Company	Use of thioamide oxazolidinones for the treatment of bone resorption and osteoporosis
GB0009803D0 (en) *	2000-04-25	2000-06-07	Astrazeneca Ab	Chemical compounds
DE10108995A1 (de) *	2001-02-23	2002-09-05	Abbott Gmbh & Co Kg	Substituierte Pyrimidinon-Derivate als Liganden von Integrinrezeptoren
DE10159453A1 (de) *	2001-12-04	2003-06-18	Merck Patent Gmbh	Verwendung von 1-Phenyl-oxazolidin-2-on-Verbindungen als Protease
DK1539739T3 (da) *	2002-08-16	2011-03-07	Janssen Pharmaceutica Nv	Piperidinylforbindelser, der selektivt binder integriner
EP2385040A1 (en) *	2003-03-14	2011-11-09	ONO Pharmaceutical Co., Ltd.	Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
US7405210B2 (en) *	2003-05-21	2008-07-29	Osi Pharmaceuticals, Inc.	Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
ATE483708T1 (de)	2004-03-08	2010-10-15	Prosidion Ltd	Pyrrolopyridin-2-carbonsäurehydrazide als inhibitoren von glykogenphosphorylase
PL1765362T3 (pl)	2004-06-04	2012-08-31	Scripps Research Inst	Kompozycje i sposoby do leczenia chorób związanych z neowaskularyzacją
EP1609784A1 (de) *	2004-06-25	2005-12-28	Boehringer Ingelheim Pharma GmbH & Co.KG	Verfahren zur Herstellung von 4-(Benzimidazolylmethylamino)-Benzamidinen
US7618983B2 (en)	2004-11-10	2009-11-17	Janssen Pharmaceutica, N.V.	Bicyclic triazole α4 integrin inhibitors
DE602005013275D1 (de)	2004-12-02	2009-04-23	Prosidion Ltd	Pyrrolopyridin-2-karbonsäureamide
EP2146722A4 (en) *	2007-05-10	2011-08-03	Amr Technology Inc	ARYL AND HETEROARYL SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND THEIR USE FOR BLOCKING THE RECOVERY OF NOREPINEPHRIN, DOPAMINE AND SEROTONINE
US9802954B2 (en)	2011-08-24	2017-10-31	Boehringer Ingelheim International Gmbh	Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma
DE102015011861B4 (de)	2015-09-10	2018-03-01	Rudolf Schindler	Neue cyclische Carboxamide als NMDA NR2B Rezeptor Inhibitoren

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6183170A (ja) *	1984-09-28	1986-04-26	Nippon Chemiphar Co Ltd	新規な１，３−オキサゾリジン−２−オン誘導体およびその製造法
US5053393A (en)	1988-07-20	1991-10-01	Monsanto Company	Novel platelet-aggregation inhibitor
US5256812A (en)	1989-01-31	1993-10-26	Hoffmann-La Roche Inc.	Carboxamides and sulfonamides
US5084466A (en)	1989-01-31	1992-01-28	Hoffmann-La Roche Inc.	Novel carboxamide pyridine compounds which have useful pharmaceutical utility
DE4017211A1 (de)	1990-05-29	1991-12-05	Merck Patent Gmbh	Oxazolidinone
JP3497164B2 (ja) *	1991-06-28	2004-02-16	スミスクライン・ビーチャム・コーポレイション	二環式フィブリノーゲン拮抗薬
US5239113A (en) *	1991-10-15	1993-08-24	Monsanto Company	Substituted β-amino acid derivatives useful as platelet aggregation inhibitors and intermediates thereof
EP0612313A1 (en) *	1991-11-14	1994-08-31	Glaxo Group Limited	Piperidine acetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation
DE4234295A1 (de)	1992-10-12	1994-04-14	Thomae Gmbh Dr K	Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
ATE236882T1 (de) *	1992-12-21	2003-04-15	Smithkline Beecham Corp	Bicyklische fibrinogen antagoniste
DK0623615T3 (da) *	1993-05-01	1999-12-13	Merck Patent Gmbh	Adhæsionsreceptor-antagonister
DE4324393A1 (de) *	1993-07-21	1995-01-26	Merck Patent Gmbh	4-Aryloxy- und 4-Arylthiopiperidinderivate
DE4332384A1 (de) *	1993-09-23	1995-03-30	Merck Patent Gmbh	Adhäsionsrezeptor-Antagonisten III
US5563158A (en) *	1993-12-28	1996-10-08	The Dupont Merck Pharmaceutical Company	Aromatic compounds containing basic and acidic termini useful as fibrinogen receptor antagonists
MA23420A1 (fr) *	1994-01-07	1995-10-01	Smithkline Beecham Corp	Antagonistes bicycliques de fibrinogene.
DE4429461A1 (de) *	1994-08-19	1996-02-22	Merck Patent Gmbh	Adhäsionsrezeptor-Antagonisten
EP0710657B1 (de) *	1994-11-02	1998-08-26	MERCK PATENT GmbH	Adhäsionsrezeptor-Antagonisten
DE19504954A1 (de) *	1995-02-15	1996-08-22	Merck Patent Gmbh	Adhäsionsrezeptor-Antagonisten

1995
- 1995-05-05 DE DE19516483A patent/DE19516483A1/de not_active Withdrawn
1996
- 1996-03-26 TW TW085103612A patent/TW378205B/zh not_active IP Right Cessation
- 1996-04-24 AT AT96106423T patent/ATE258548T1/de not_active IP Right Cessation
- 1996-04-24 PT PT96106423T patent/PT741133E/pt unknown
- 1996-04-24 ES ES96106423T patent/ES2213758T3/es not_active Expired - Lifetime
- 1996-04-24 DE DE59610900T patent/DE59610900D1/de not_active Expired - Fee Related
- 1996-04-24 DK DK96106423T patent/DK0741133T3/da active
- 1996-04-24 EP EP96106423A patent/EP0741133B1/de not_active Expired - Lifetime
- 1996-04-26 UA UA96041680A patent/UA53608C2/uk unknown
- 1996-04-29 RU RU96108122/04A patent/RU2162086C2/ru not_active IP Right Cessation
- 1996-04-30 AU AU51969/96A patent/AU708813B2/en not_active Ceased
- 1996-04-30 PL PL96314044A patent/PL187000B1/pl not_active IP Right Cessation
- 1996-05-02 JP JP13413796A patent/JP4202438B2/ja not_active Expired - Fee Related
- 1996-05-03 ZA ZA963535A patent/ZA963535B/xx unknown
- 1996-05-03 NO NO961813A patent/NO305906B1/no not_active IP Right Cessation
- 1996-05-03 TR TR96/00359A patent/TR199600359A2/xx unknown
- 1996-05-03 US US08/642,268 patent/US6455529B1/en not_active Expired - Fee Related
- 1996-05-03 AR ARP960102444A patent/AR003121A1/es not_active Application Discontinuation
- 1996-05-03 CA CA002175767A patent/CA2175767C/en not_active Expired - Fee Related
- 1996-05-03 BR BR9602150A patent/BR9602150A/pt not_active Application Discontinuation
- 1996-05-03 HU HU9601176A patent/HUP9601176A3/hu unknown
- 1996-05-03 CN CNB961062258A patent/CN1134423C/zh not_active Expired - Fee Related
- 1996-05-03 CZ CZ19961295A patent/CZ291621B6/cs not_active IP Right Cessation
- 1996-05-06 KR KR1019960014643A patent/KR100462176B1/ko not_active Expired - Fee Related
- 1996-05-06 CO CO96022358A patent/CO4950623A1/es unknown
- 1996-05-06 SK SK573-96A patent/SK282563B6/sk unknown

Also Published As

Publication number	Publication date
MX9601659A (es)	1997-07-31
AU708813B2 (en)	1999-08-12
DE19516483A1 (de)	1996-11-07
SK282563B6 (sk)	2002-10-08
CN1134423C (zh)	2004-01-14
EP0741133B1 (de)	2004-01-28
DK0741133T3 (da)	2004-04-26
CA2175767A1 (en)	1996-11-06
AU5196996A (en)	1996-11-14
HU9601176D0 (en)	1996-06-28
SK57396A3 (en)	1996-11-06
ZA963535B (en)	1996-08-08
AR003121A1 (es)	1998-07-08
HUP9601176A2 (hu)	1998-07-28
CZ129596A3 (en)	1996-11-13
HUP9601176A3 (en)	1998-08-28
UA53608C2 (uk)	2003-02-17
US6455529B1 (en)	2002-09-24
JP4202438B2 (ja)	2008-12-24
RU2162086C2 (ru)	2001-01-20
CA2175767C (en)	2008-07-29
TW378205B (en)	2000-01-01
PT741133E (pt)	2004-06-30
KR960041180A (ko)	1996-12-19
CN1138037A (zh)	1996-12-18
EP0741133A2 (de)	1996-11-06
PL314044A1 (en)	1996-11-12
DE59610900D1 (de)	2004-03-04
CO4950623A1 (es)	2000-09-01
NO961813L (no)	1996-11-06
CZ291621B6 (cs)	2003-04-16
PL187000B1 (pl)	2004-04-30
ES2213758T3 (es)	2004-09-01
BR9602150A (pt)	1998-06-30
JPH08301857A (ja)	1996-11-19
KR100462176B1 (ko)	2005-07-07
ATE258548T1 (de)	2004-02-15
NO305906B1 (no)	1999-08-16
EP0741133A3 (de)	1997-01-29
TR199600359A2 (tr)	1996-11-21

Publication	Publication Date	Title
DE59608860D1 (de)	2002-04-11	Bogenrotationsdruckmaschine
NO961813D0 (no)	1996-05-03	Adhesjonsreseptorantagonister
EP0861320A4 (en)	2000-05-24	SEQUESTRIN
DE59610613D1 (de)	2003-08-28	Leibungsbefestigungswinkel
ATE198470T1 (de)	2001-01-15	Alkenyl-benzoylguanidine
ATE240972T1 (de)	2003-06-15	Cyclopeptolide
DE69622529D1 (de)	2002-08-29	Chromerzschmelzreduktionsverfahren
DE59610604D1 (de)	2003-08-21	Läuterbottich
ATA119896A (de)	2002-04-15	Scheibenmähwerk
FI2074U1 (fi)	1995-08-29	Braenslepack
FI2004U1 (fi)	1995-07-07	Foervaringsstaell
DE59607421D1 (de)	2001-09-06	Giesspfannenschieber
BR7501437U (pt)	1997-11-18	Leiteira
BR7500838U (pt)	1997-05-13	Vassourágua
BR7502853U (pt)	1998-03-24	Faixa-surf
BR7502714U (pt)	1998-05-19	Impresscard
BR7502653U (pt)	1998-05-12	Publi-taxi
BR7502098U (pt)	1998-04-14	T-compacto
BR7502025U (pt)	1998-04-14	Kantil
BR7501939U (pt)	1998-04-14	Caixa-ambalgem
BR7501858U (pt)	1997-08-19	Tellelight
BR7501485U (pt)	1997-11-18	Fibropiso
BR7501467U (pt)	1997-11-18	Vassourágua
BR9501801A (pt)	1997-08-12	Taxialerta
BR7501426U (pt)	1997-11-18	Búlica

Legal Events

Date	Code	Title	Description
2005-01-03	MM1K	Lapsed by not paying the annual fees